Neuropsychological aspects of coinfection with HIV and hepatitis C virus

被引:45
|
作者
Hilsabeck, RC
Castellon, SA
Hinkin, CH
机构
[1] S Texas Vet Hlth Care Syst, Psychol Serv, San Antonio, TX 78229 USA
[2] Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA USA
[3] Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA
关键词
D O I
10.1086/429494
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infection with hepatitis C virus (HCV) is commonly seen in persons with human immunodeficiency virus (HIV) infection, because the viruses share risk factors for transmission; coinfection is a leading cause of morbidity and mortality among HIV-infected persons. Neuropsychological consequences of HIV infection are well established, and studies of HCV-infected persons have revealed neuropsychiatric dysfunction in this population as well. Investigators now are focusing on neuropsychological sequelae of coinfection with HIV and HCV, and preliminary results suggest that coinfection has a possible deleterious effect on global cognitive functioning consistent with frontal-subcortical dysfunction. Data on neuropsychiatric symptoms in coinfected persons are inconclusive at this time and are complicated by important differences in study populations (e. g., injection drug use and disease severity). This review summarizes what is known about neuropsychological aspects of monoinfection with HIV and HCV, as well as coinfection, discusses implications of these findings, and suggests future directions for this research area.
引用
收藏
页码:S38 / S44
页数:7
相关论文
共 50 条
  • [31] Coinfection by hepatitis B virus and hepatitis C virus
    Pontisso, P
    Gerotto, M
    Benvegnu, L
    Chemello, L
    Alberti, A
    ANTIVIRAL THERAPY, 1998, 3 : 137 - 142
  • [32] HIV coinfection with hepatitis C and hepatitis B
    Smith J.O.
    Sterling R.K.
    Current Infectious Disease Reports, 2006, 8 (5) : 409 - 418
  • [33] Coinfection with HIV and hepatitis C virus and immune restoration during HAART
    Manfredi, R
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (02) : 298 - 299
  • [34] Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection
    Shmagel, K. V.
    Saidakova, E. V.
    Shmagel, N. G.
    Korolevskaya, L. B.
    Chereshnev, V. A.
    Robinson, J.
    Grivel, J-C
    Douek, D. C.
    Margolis, L.
    Anthony, D. D.
    Lederman, M. M.
    HIV MEDICINE, 2016, 17 (08) : 581 - 589
  • [35] Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment
    Hua, Lei
    Andersen, Janet W.
    Daar, Eric S.
    Glesby, Marshall J.
    Hollabaugh, Kimberly
    Tierney, Camlin
    AIDS, 2013, 27 (17) : 2725 - 2734
  • [36] Coinfection with Hepatitis C Virus and HIV: More than Double Trouble
    Piroth, Lionel
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (04) : 623 - 625
  • [37] Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV
    Letendre, Scott
    Paulino, Amy D.
    Rockenstein, Edward
    Adame, Anthony
    Crews, Leslie
    Cherner, Mariana
    Heaton, Robert
    Ellis, Ronald
    Everall, Ian P.
    Grant, Igor
    Masliah, Eliezer
    JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (03): : 361 - 370
  • [38] Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV
    Balasubramanian, A
    Koziel, M
    Groopman, JE
    Ganju, RK
    CLINICAL INFECTIOUS DISEASES, 2005, 41 : S32 - S37
  • [39] Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection
    Blackard, Jason T.
    Hiasa, Yoichi
    Smeaton, Laura
    Jamieson, Denise J.
    Rodriguez, Irma
    Mayer, Kenneth H.
    Chung, Raymond T.
    JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (12): : 1765 - 1773
  • [40] The Impact of HIV Coinfection on Hepatitis C Virus (HCV) Treatment Initiation
    Henegar, Cassidy E.
    Beckerman, Robin
    Fusco, Jennifer
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 494 - 495